Background {#Sec1}
==========

Nosocomial infections (NI) are still an important issue in neurocritical care due to secondary brain damage and the increased morbidity and mortality of primary acute neurocritical care patients \[[@CR1]--[@CR5]\]. NI is associated with higher antibiotic consumption, thereby worsening the epidemiological situation in the intensive care unit by increasing the occurrence of multidrug-resistant bacteria \[[@CR6]\]. For these reasons, they have a significant economic impact because they prolong stay \[[@CR7]--[@CR10]\] in the neurointensive care unit (NICU) and the higher frequency of diagnostic and therapeutic processing significantly raises healthcare costs.

Nosocomial infections can be caused by many risk factors, not all of which have been fully investigated. However, keeping a hygienic and epidemiological regime of critical care \[[@CR11]--[@CR13]\] and the rational use of antibiotics makes a significant impact \[[@CR14], [@CR15]\].

The primary aim of this study was to determine incidence of nosocomial infections and multidrug-resistant bacteria and seek predictors of nosocomial infections in a preventive multimodal nosocomial infection protocol in our neurocritical care. The secondary aim focused on their impact on stay, mortality and cost in the NICU.

Method {#Sec2}
======

Study design and setting {#Sec3}
------------------------

A monocentric 10-year observation prospective cohort study was conducted in the entire population of 3464 patients with acute brain disease, admitted to an eight-bed, adult neurological and neurosurgical intensive care unit in the Neurocenter of the 900-bed Regional Hospital with a catchment area of approximately half a million people. The study was performed in the NICU, which consists of four different rooms: one room with one bed, two rooms with two beds and one room with three beds. The study was approved by the Liberec hospital Ethics Committees for Multicentric Clinical Trials.

We prospectively examined the following determined demographic and clinical parameters in our local NICU: brain diagnosis, type of admission (primary, secondary to 24 hours and after 24 hours; acute or planned; rehospitalisation), admission and overall Therapeutic Intervention Scoring System (TISS), admission Glasgow Coma Scale (GCS), admission Acute Physiology and Chronic Health Evaluation (APACHE) II score, length of stay in the NICU, mortality in the NICU, Glasgow Outcome Scale (GOS) upon discharge from the NICU, C-reactive protein (CRP), operations (amount, day of hospital and NICU hospitalisation, acute or planned, reoperation, time and type of operation), American Society of Anesthesiologists (ASA) Score, drainage, airways, mechanical ventilation, catheters (artery, central venous, urine) and tubes, administration of corticoids, transfusions, ulcer prophylaxis and diabetes mellitus.

Preventive multimodal nosocomial infection protocol {#Sec4}
---------------------------------------------------

In the preventive multimodal nosocomial infection protocol, we categorised hygienic and epidemiological status and antibiotic policy.

Hygienic and epidemiological regime {#Sec5}
-----------------------------------

The basis of the hygienic and epidemiological regime in our preventive multimodal protocol consisted of cleanliness, disinfection, sterilisation, barrier patient care techniques, the separation of clean and contaminated procedures and the regular monthly exchange of disinfectants. We categorised principles for staff, patients and facilities.

### 1/Staff and visitors {#Sec6}

The foremost part of this protocol was maintaining the hygiene and disinfection of all staff members' hands before and after care for each patient, enabled by the bottled disinfectant provided at each entrance and each bed. This rule was also required for visitors. Staff members were not allowed to wear jewellery or watches on their hands and had to keep their fingernails cut short. Internal staff had to wear new, clean, special NICU clothing every day, a protective coat when outside the NICU, and masks, surgical caps and gowns when caring for isolated patients or during invasive medical procedures. Aprons were worn while washing patients. External staff as well as visitors wore surgical gowns, but not overshoes, and only 2 family members were allowed in the patient's room at a time.

### 2/Patients {#Sec7}

Care of the patient was performed on the principle of barrier care techniques. Tools for individual patients including disinfection, stethoscopes, thermometers and washing aids were available by each bed. Patients were washed twice a day with liquid soap. Disinfection soap was used only before entering the operating theatre. Oral hygiene included cleaning teeth with our special toothbrushes with chlorhexidine and subglottic secretion drainage, after washing, the patient's body was rubbed with a non-allergic cream. Patients' clothes and bedding were changed twice a day. Dirty laundry was put in special sacks rather than dropped freely on the floor.

Basic principles of care for drainage, catheters, infusion, suction from the airway, breathing circuit sets, tubes included: 1/single-use products, 2/closed systems, 3/the minimum necessary duration, 4/minimal and only necessary disconnection, using the port system, 5/the regular (peripheral venous catheters, all infusion sets, connecting tubes and ports) and irregular (central venous catheters, endotracheal tubes and tracheostomy) exchange of all these tubes and catheters was made according to the exchange protocol. Invasive procedures included the sterile insertion of systems and regularly exchanged, fully covering and constantly dry sterile wound covers. Furthermore, the protocol included the hourly monitoring of residual gastric volume.

The protocol included the regular microbiological screening of nose, throat, trachea, skin, urine and rectum from admission and then every three days, as well as every catheter except the peripheral venous for the timely detection of multidrug-resistant bacteria extended spectrum beta-lactamases (ESBL) or methicillin-resistant Staphylococcus aureus (MRSA) or Vancomycin-resistant enterococcus (VRE).

Patients with an infection or with multidrug-resistant bacteria ESBL and MRSA were completely isolated.

### 3/Facilities {#Sec8}

Daily cleaning with disinfection of surfaces including the bed, monitors, and other equipment around the bed, door handles and floors was conducted three times a day. Walls were cleaned once a day for the isolated patients, otherwise once a week. Each room had its own bucket for surfaces and walls. The floors were mopped using a system of two buckets and a cloth, with each room having its own. All cupboards containing materials and medical equipment were cleaned with disinfectant once a week. Waste was sorted and disposed of using specially marked plastic containers and sacks. After the patient was discharged, the bed was completely disinfected. The room was painted with a washable coating once a year.

Antibiotic policy {#Sec9}
-----------------

The protocol included the monitoring of antibiotics in a local computer database. Antibiotic policy was implemented in close cooperation with the antibiotic centre and intended to keep the rational antibiotic policy aim of eliminating the overuse of antibiotics, especially those not used during bacterial pathogeny colonisation. The indications for using prophylactic antibiotics were surgical procedures (operation, external ventricular and lumbar drainage, intracranial sensors), liquorrhoea and aspiration. The protocol required maintaining dose and timing before the operation, perioperative administration for lengthy operations, and the non-prolongation of antibiotic administration after the operation or drainage or implantation of sensors. Empiric antibiotic therapy was to start after samples were taken for microbiological examination to enable their administration according to culture and sensitivity.

Nosocomial infection {#Sec10}
--------------------

Infections were identified according to clinical symptoms such as fever, bacterial pathogens from secretions, liquor, urine, wounds, catheters, haemoculture with a defined microbiology colony count, imaging methods, biochemical and haematological laboratory tests. Nosocomial infections were defined as infections starting after two calendar days in the hospital. We identified nosocomial infections in 198 patients (5.7%). There were more wound infections (2.1%), than respiratory (1.8%), urinary (1.0%), bloodstream (0.7%) and others (0.1%).

Statistical analysis {#Sec11}
--------------------

Parametric *t*-tests or non-parametric Mann-Whitney U tests were used for comparison of continuous variables. Comparison of categorical parameters was carried out using Chi-square or Fisher tests as appropriate. Univariate logistic regression was used for identifying prognostic factors of NI. Factors from univarite analysis with level of significance defined as *p* \<0.1 were used for multivarite regression analysis, factors with *p* value \<0.1 were left in the model. *P*--values of less than 0.05 were considered significant. STATISTICA 13.2 (TIBCO Software Inc., Palo Alto, CA, USA) software was used for statistical analyses. The control group was defined as patients without nosocomial infections.

Results {#Sec12}
=======

We did not find any demographic differences such as age, gender, weight or body mass index between the NI group and the control group, as can be seen in Table [1](#Tab1){ref-type="table"}. However, there was a difference in diagnosis, more patients with stroke and hydrocephalus had more NI than those with other diagnoses. According to the scoring system, patients with nosocomial infection upon admission had significantly lower GCS scale and higher APACHE II. Prognostic parameters were also significantly higher in the NI patients group. They stayed in the NICU longer, had higher mortality and worse Glasgow Coma Scale upon discharge. They were also more expensive economically, and had significantly higher total TISS.Table 1Demographic and clinical data of population of patients with acute brain disease, with or without nosocomial infectionParameterUnitTotal populationNI groupControl group*p* valueNumber totalpts3464 (100%)198 (5.7%)3266 (94.3%)Januarypts327 (9.4%)7 (3.6%)310 (9.5%)Februarypts249 (7.2%)19 (9.6%)230 (7.0%)Marchpts267 (7.7%)19 (9.6%)248 (7.6%)Aprilpts305 (8.8%)13 (6.6%)292 (8.9%)Maypts269 (7.8%)21 (10.6%)248 (7.6%)Junepts290 (8.4%)17 (8.6%)273 (8.4%)0.660Julypts310 (8.9%)19 (9.6%)291 (8.9%)Augustpts274 (7.98%)12 (6.1%)262 (8.0%)Septemberpts307 (8.9%)14 (7.1%)293 (9.0%)Octoberpts280 (8.1%)13 (6.6%)267 (8.2%)Novemberpts291 (8.4%)17 (8.6%)274 (8.4%)Decemberpts295 (8.5%)17 (8.6%)278 (8.5%)Agepts57.2±15.656.3±15.60.416Malepts2004 (57.9%)117 (59.1%)1887 (57.8%)0.716Weightkg78.7±17.177.6±15.80.423BMI26.8±5.026.8±4.90.966NICU stayday15.3±11.74.8±5.4\<0.001Admission Primarypts746 (21.5%)47 (23.7%)699 (21.4%) Secondary to 24 hpts739 (21.3%)51 (25.8%)688 (21.1%)0.134 Secondary after 24 hpts1979 (57.1%)100 (50.5%)1879 (57.5%)Acute admissionpts1020 (29.4%)70 (35.4%)950 (29.1%)\<0.001Rehospitalisationpts40 (1.22%)4 (2.0%)44 (1.3%)0.331Diagnoses Strokepts1498 (43.2%)110 (55.6%)1388 (42.5%) Traumapts472 (13.6%)27 (13.6%)445 (13.6%) Tumourpts1078 (31.1%)33 (16.7%)1045 (32.0%)\<0.001 Epilepsypts133 (3.8%)3 (1.5%)130 (4.0%) Hydrocephaluspts119 (3.4%)13 (6.6%)106 (3.2%) Infectionpts88 (2.5%)11 (5.6%)77 (2.4%) Otherspts75 (2.2%)1 (0.5%)74 (2.3%) Strokepts\<0.001  Ischemicpts580 (16.7%)21 (10.6%)559 (17.1%)  ICHpts471 (13.6%)49 (24.7%)422 (12.9%)  SAHpts447 (12.9%)40 (20.2%)407 (12.5%)TISS on admission54.7±1.956.0±1.7\<0.001TISS total270632.8±231533.160415.1±92140..3\<0.001GCS on admission11.5±3.513.1±3.0\<0.001APACHE II on admission15.1±5.511.8±5.8\<0.001GOS on NICU discharge3.1±1.13.9±1.1\<0.001Mortality in NICUpts152 (4.4%)21 (10.6%)131 (4.0%)\<0.001Mortality in NICUday16.2±10.47.5±5.7\<0.001CRP on admission31.7±45.617.5±39.1\<0.001CRP postoperative30.0±44.414.0±33.0\<0.001CRP 1 day after operation59.8±56.931.6±39.6\<0.001CRP highest in NICU stay228.0±122.566.1±80.3\<0.001*BMI* body mass index, *NICU* neurointensive care unit, *ICH* intracerebral haemorrhage, *SAH* subarachnoid haemorrhage, *TISS* Therapeutic Intervention Scoring System, *GCS* Glasgow Coma Scale, *APACHE* Acute Physiology and Chronic Health Evaluation, *GOS* Glasgow Outcome Scale, *CRP* C-reactive protein

Characteristics of brain operations can be seen in Table [2](#Tab2){ref-type="table"}. Patients who had undergone operations and drainage had significantly higher nosocomial infection. These patients had more endotracheal tubes and tracheostomies, mechanical ventilations (Table [3](#Tab3){ref-type="table"}), artery and central venous catheters (Table [4](#Tab4){ref-type="table"}), urine and gastrointestinal tubes (Table [5](#Tab5){ref-type="table"}).Table 2Characteristics of brain operationsOperationUnitTotal population *N*=2231NI group *N*=151Control group *N*=2080*p* valueOperationpts2231(64.4%)151(76.3%)2080 (63.7%)\<0.001More than 1 operationpts214(9.6%)42(27.8%)172(8.3%)\<0.001ASA score3.8±1.03.1±1.1\<0.001Day of hospitalisationday5.5±9.87.1±17.10.430Day of NICU1.6±1.31.3±1.10.535Acute operationpts905(40.6%)106(70.2%)799(38.4%)\<0.001Reoperationpts479(21.5%)58(38.4%)421(20.2%)\<0.001Time of operationminutes151.9±108.4137.7±89.40.080Craniotomypts1361(61.0%)82(54.3%)1279(61.5%)0.080Craniectomypts363(16.3%)50(33.1%)313(15.0%)\<0.001Trepanationpts227(10.2%)23(15.2%)204(9.8%)0.033Hypophysispts85(3.8%)0(0.0%)85(4.1%)0.011Shuntpts108(4.8%)12(7.9%)96(4.6%)0.066Otherspts99(4.4%)9(6.0%)90(4.3%)0.347Drainagepts1678(75.2%)131(86.8%)1547(74.4%)\<0.001 Redonpts858(38.5%)49(32.5%)809(38.9%)0.001 Time overallday2.0±0.91.8±1.30.395 Gravity drainagepts807(36.2%)75(49.7%)732(35.2%)0.029  Time overallday3.5±2.12.7±2.20.004 Lumbarpts218(9.8%)36(23.8%)182(8.8%)\<0.001  Day overallday7.7±5.55.1±3.2\<0.001 Ventricularpts138(6.2%)21(13.9%)117(5.6%)\<0.001  Day overallday13.4±9.95.9±4.3\<0.001*ASA* American Society of Anesthesiologists, *NICU* neurointensive care unitTable 3Characteristics of respiratory proceduresParameterUnitTotal population *N*=3646NI group *N*=198Control group\
*N*=3266*p* valueAirwayspts710 (20.5%)112 (56.6%)598 (18.3%)\<0.001 ETTpts327(46.1%)15(13.4%)312(52.2%) TSKpts161(22.7%)29(25.9%)132(22.1%)\<0.001 ETT/TSTpts222(31.3%)68(60.7%)154(25.8%) ETK time NICUday4.2±2.12.9±2.2\<0.001 ETK timeday4.4±2.12.9±2.3\<0.001 TSK time NICUday14.2±10.28.4±7.8\<0.001 TSK timeday21.8±34.621.6±62.20.980 TSK type Classicpts43(11.2%)9(9.3%)34(11.9%)0.456 TSK NICU madepts250(65.3%)75(77.3%)175(61.2%)0.006Mechanical ventilationpts543(15.7%)87(43.9%)456(14.0%)\<0.001 Invasivepts539(99.3%)87(100.0%)452(99.1%)\<0.001 Timeday14.1±9.95.6±5.9\<0.001Indication Neuropts414(76.2%)54(62.1%)360(78.9%)0.161 Respiratorypts32(5.9%)7(8.0%)25(5.5%)*ETT* endotracheal tube, *TST* tracheostomy tube, *NICU* neurointensive care unitTable 4Characteristics of vascular cathetersParameterUnitTotal population *N*=3464NI group *N*=198Control group *N*=3266*p* valueArtery catheterpts907(26.2%)90(45.5%)817(25.0%)\<0.001Timeday9.5±6.67.5±3.70.018Number of artery catheters923(100.0%)91(100.0%)832(100.0%) Radialispts873(94.6%)89(97.8%)784(94.2%)0.165 Brachialispts14(1.5%)0(0.0%)14(1.7%)0.211 Femoralispts36(3.9%)2(2.2%)34(4.1%)0.371 Leftpts598(64.8%)64(70.3%)534(64.2%)0.275 Time in NICUday8.27±5.454.10±3.360.094 Time allday8.41±5.404.41±3.430.377 Made in NICUpts216(23.4%)47(51.6%)169(20.3%)\<0.001 Made in operation theatrepts607(65.8%)46(50.5%)561(67.4%)0.001 Cultivation of catheterpts691(74.9%)74(81.3%)617(74.2%)0.157  Positivepts113(16.4%)18(24.3%)95(15.4%)0.050  STSPpts100(88.5%)13(72.2%)87(91.6%)0.018 Haemoculture cultivationpts164(17.8%)31(34.1%)133(16.0%)\<0.001  Positivepts34(20.7%)9(29.0%)25(18.8%)0.206  STSPpts18(52.9%)3(33.3%)15(60.0%)0.169Central venous catheterpts372(10.7%)64(32.3%)308(9.4%)\<0.001Time overallday9.9±7.47.5±3.70.077Number of venous catheter378(100%)66(100%)312(100%) Subclaviapts336(88.9%)60(90.9%)276(88.5%)0.308 Jugularispts19(5.0%)1(1.5%)18(5.8%)0.157 Femoralispts16(4.2%)4(6.1%)12(3.8%)0.398 Axilarispts7(1.9%)1(1.5%)6(1.9%)0.836 Rightpts323(85.4%)59(89.4%)264(84.6%)0.164 Type one-linepts75(19.8%)10(15.2%)65(20.8%) Type two-linepts192(50.8%)39(59.1%)153(49.0%)0.214 Type three-linepts64(16.9%)8(12.1%)56(17.9%) Time in NICUday8.20±7.314.70±4.92\<0.001 Time allday11.19±8.707.24±5.50\<0.001 Made in NICUpts162(42.9%)41(62.1%)121(38.8%)\<0.001 Made in operation theatrepts14(3.7%)1(1.5%)13(4.2%)0.309 Cultivation of catheterpts261(69.0%)45(68.2%)216(69.2%)0.977  Positivepts52(19.9%)16(35.6%)36(16.7%)0.004  STSPpts40(76.9%)10(62.5%)30(83.3%)0.010 Haemoculture cultivationpts72(19.0%)16(24.2%)56(17.9%)0.090  Positivepts15(20.8%)2(12.5%)13(23.2%)0.352  STSPpts13(86.7%)2(100.0%)11(84.6%)0.551*NICU* neurointensive care unit, *STSP* Staphylococcus speciesTable 5Characteristics of urine and gastrointestinal proceduresParameterUnitTotal population *N*=3464NI group *N*=198Control group *N*=3266*p* valueUrine catheterpts3166(91.4%)189(95.5%)2927(89.6%)0.008 Epicystostomypts6(0.2%)1(0.5%)5(0.2%)0.247 Timeday15.5±11.64.7±5.5\<0.001 Time overallday22.6±13.112.8±9.7\<0.001Gastrointestinal tubepts904(26.1%)128(64.6%)776(23.8%)\<0.001 Nasogastric tubepts882(25.5%)125(63.1%)757(23.2%)\<0.001 Timeday15.4±11.26.2±6.9\<0.001 Time overallday19.6±12.610.7±9.4\<0.001

We confirmed transfusions (*p*\<0.001), ulcer prophylaxis (*p*\<0.001) and corticoids (*p*=0.002) as further parameters influencing nosocomial infection, but we did not see more nosocomial infection in patients with diabetes mellitus (*p*=0.203), (Table [6](#Tab6){ref-type="table"}).Table 6Further monitored parameters influencing onset of nosocomial infectionParameterUnitTotal population *N*=3464NI group *N*=198Control group *N*=3266*p* valueCorticoidspts1172(33.8%)47(23.7%)1125(34.4%)0.002 Dexamethasonepts944(27.3%)31(15.7%)913(28.0)\<0.001 Methylprednisolonepts35(1.0%)5(2.5%)30(0.9%)0.028 Hydrocortisonepts241(7.0%)12(6.1%)229(7.0%)0.610 Timeday6.37±8.783.58±2.56\<0.001Transfusionspts176(5.1%)41(20.7%)135(4.1%)\<0.001 Number2.46±8.782.57±2.560.695 Blood lossml523.77±668.07380.74±478.760.019 Haemoglobin93.35±21.03115.34±21.62\<0.001Ulcer prophylaxispts1838(53.1%)134(67.7%)1704(52.2%)\<0.001 One medicinepts1669(48.2%)119(60.1%)1550(47.5%)0.406 Sucralfatepts758(21.9%)26(13.1%)732(22.4%)0.002 H2 antagonistpts196(5.7%)27(13.6%)169(5.2%)\<0.001 Omeprazolepts1062(30.7%)97(49.0%)965(29.5%)\<0.001Diabetes Mellituspts491(14.2%)22(11.1%)469(14.4%)0.203Op. wound complicationpts133(3.8%)35(17.7%)98(3.0%)\<0.001Liquorrhoeapts81(2.3%)23(11.6%)58(1.8%)\<0.001

ESBL occurred in 1.9% and MRSA in 1.5% of the total population, without differences between NI group patients and the control group (Table [7](#Tab7){ref-type="table"}). We did not have any case of vancomycin-resistant enterococcus.Table 7Multidrug-resistant bacteria ESBL and MRSA in NICUParameterUnitTotal population *N*=3464NI group *N*=198Control group *N*=3266*p* valueMultidrug-resistantpts116(3.3%)12(6.1%)104(3.2%)0.029ESBLpts67(1.9%)6(3.0%)61(1.9%)0.566 On admissionpts36(1.0%)4(2.0%)32(1.0%)0.249  Nosepts11(0.3%)1(0.5%)10(0.3%)0.986  Throatpts21(0.6%)4(2.0%)17(0.5%)0.051  Tracheapts15(0.4%)1(0.5%)14(0.4%)0.725  Urinepts19(0.5%)0(0.0%)19(0.6%)0.106  Rectumpts31(0.9%)3(1.5%)28(0.9%)0.848  Brainpts2(0.1%)1(0.5%)1(0.0%)0.039  Otherspts5(0.1%)1(0.5%)4(0.1%)0.369MRSApts52(1.5%)7(3.5%)45(1.4%)0.320 On admissionpts22(0.6%)0(0.0%)22(0.7%)0.015  Nosepts27(0.8%)4(2.0%)23(0.7%)0.766  Throatpts11(0.3%)1(0.5%)10(0.3%)0.632  Tracheapts14(0.4%)2(1.0%)12(0.4%)0.916  Brainpts5(0.1%)1(0.5%)4(0.1%)0.652  Haemoculturepts1(0.0%)0(0.0%)1(0.0%)0.690  Otherspts5(0.1%)0(0.0%)5(0.2%)0.354*NICU* neurointensive care unit, *ESBL* Extended spectrum beta-lactamase, *MRSA* Methicillin-resistant Staphylococcus aureus

Antibiotics policy is shown in Table [8](#Tab8){ref-type="table"}. Antibiotic prophylaxis was given to 63% of the total population, mostly (59.2%) in association with operations. In 33.4% of the patients it was only administered in the operating theatre. Prolonged administration in the NICU was associated with more NIs (*p*=0.017). Antibiotic therapy was given to 9.7% of the total population.Table 8Administration of antibiotics in NICUParameterUnitTotal population *N*=3464NI group *N*=198Control group *N*=3266*p* valueAntibiotic prophylaxispts2183(63.0%)127(64.1%)2056(63.0%)0.736 One prophylaxispts1931(55.7%)91(46.0%)1840(56.3%)\<0.001 Operationpts2049(59.2%)116(58.6%)1933(59.2%)0.222  Only operation theatrepts1157(33.4%)61(30.8%)1096(33.6%)  Operation 1 dosepts924(26.7%)42(21.2%)882(27.0%)  Operation 2 dosespts191(5.5%)14(7.1%)177(5.4%)0.006  Operation 3 dosespts40(1.2%)4(2.0%)36(1.1%)  Operation 4 dosespts2(0.1%)1(0.5%)1(0.0%)  NICUday4.96±5.693.31±2.880.017Others Aspirationpts51(1.5%)5(2.5%)46(1.4%)0.218 Suspected infectionpts49(1.0%)2(1.0%)47(1.4%)0.600 Traumapts30(1.4%)2(1.0%)28(0.9%)0.844 Liquorrhoeapts46(0.9%)6(3.0%)40(1.2%)0.034 Drainagepts35(1.3%)6(3.0%)29(0.9%)0.004 Otherspts31(1.0%)4(2.0%)27(0.8%)0.090 NICUDay7.75±4.614.54±3.33\<0.001Type of antibiotic Cefazolinpts1733(50.0%)106(53.5%)1627(49.8%)0.242 Amoxicillin clavulanatepts362(10.5%)30(15.2%)332(10.2%)0.028 Clindamycinpts127(3.7%)5(2.5%)122(3.7%)0.351Antibiotic therapypts335(9.7%)169(85.4%)166(5.1%)\<0.001One infectionpts326(9.4%)161(81.3%)165(5.1%)0.019One antibioticpts220(6.4%)100(50.5%)120(3.7%)0.061Two antibioticspts78(2.3%)44(22.2%)34(1.0%)NICU startpts224(6.5%)151(76.3%)73(2.2%)\<0.001Empirical therapypts201(5.8%)101(51.0%)100(3.1%)0.929According to cultivationpts189(5.5%)106(53.5%)83(2.5%)0.019Days of ATB allday8.82±6.896.09±4.95\<0.001Type of antibiotic Ceftriaxonepts34(1.0%)9(4.5%)25(0.8%)0.003 Ceftazidimepts6(0.2%)3(1.5%)3(0.1%)0.982 Meropenempts75(2.2%)48(24.2%)27(0.8%)0.008 Penicillinpts13(0.4%)5(2.5%)8(0.2%)0.378 Oxacillinpts23(0.7%)17(8.6%)6(0.2%)0.020 Ciprofloxacinday84(2.4%)57(28.8%)27(0.8%)\<0.001 Trimethoprimpts17(0.5%)10(5.1%)7(0.2%)0.478Gentamicinpts25(0.7%)15(7.6%)10(0.3%)0.321Otherspts71(2.0%)29(14.6%)42(1.3%)0.068*NICU* neurointensive care unit, *ATB* antibiotic

We compared patients with NI onset in the NICU (77.3%) with NI present on admission (22.7%), (Table [9](#Tab9){ref-type="table"}). We identified 153 (4.4%; wound 1.0%, respiratory 1.7%, urinary 0.9%, bloodstream 0.6% and other 0.1%) patients with NI onset in the NICU. Patients with NI onset in the NICU stayed in the NICU significantly longer, and were more expensive, but these patients did not have higher mortality. Multivariate logistic regression analysis seeking significant predictors for onset of NI in the NICU can be seen in Table [10](#Tab10){ref-type="table"}. Our results showed that strong predictors on onset of NI in our neurocritical care were accesses such as airways and urine catheters, NICU stay, antibiotic prophylaxis, wound complications and transfusion. This analysis did not find the multidrug-resistant bacteria as ESBL and MRSA to be a predictor of NI.Table 9Nosocomial infections on admission and onset in the NICUParameterUnitNI totalNI on admissionNI onset in NICU*p* valueNumber totalpts198 (100%)45 (22.7%)153 (77.3%)Agepts57.2±15.653.7±16.958.3±15.10.086Malepts117(59.1%)18(40.0%)63(41.2%)\<0.001NICU stayday15.3±11.76.9±7.217.7±11.6\<0.001Diagnoses Strokepts110(55.6%)13(28.9%)97(63.4%) Traumapts27(13.6%)3(6.7%)24(15.7%) Tumourpts33(16.7%)13(28.9%)20(13.1%) Epilepsypts3(1.5%)0(0.0%)3(2.0%)\<0.001 Hydrocephaluspts13(6.6%)7(15.6%)6(3.9%) Infectionpts11(5.6%)9(20.0%)2(1.3%) Otherspts1(0.5%)0(0.0%)1(0.7%)TISS on admission54.7±1.956.0±17954.3±1.8\<0.001TISS total270632.8±231533.1111173.7±231533.1309492.6±234698.9\<0.001GCS on admission11.5±3.512.0±3.311.3±3.50.234APACHE II on admission15.1±5.513.6±5.415.4±5.50.099GOS on NICU discharge3.1±1.13.5±1.23.0±1.10.015Mortality in NICUpts21(10.6%)3(6.7%)18(11.8%)0.329Operationpts151(76.3%)37(82.2%)114(74.5%)0.285Airwayspts112(56.6%)16(35.6%)96(62.7%)0.001Mechanical ventilationpts87(43.9%)7(15.6%)80(52.3%)\<0.001Artery catheterpts90(45.5%)6(13.3%)84(54.9%)\<0.001Central venous catheterpts64(32.3%)11(24.4%)53(34.6%)0.199Lumbar drainagepts36(18.2%)5(11.1%)31(20.3%)0.162Ventricular drainagepts21(10.6%)3(6.7%)18(11.8%)0.329Corticoidspts47(23.7%)11(24.4%)36(23.5%)0.899Transfusionspts41(20.7%)5(11.1%)36(23.5%)0.071Ulcer prophylaxispts134(67.7%)27(60.0%)107(69.9%)0.210Diabetes Mellituspts22(11.1%)3(6.7%)19(12.4%)0.280Antibiotic prophylaxispts127(64.1%)23(51.1%)104(68.0%)0.038Antibiotic therapypts169(85.4%)28(62.2%)141(92.2%)\<0.001ESBLpts6(3.0%)1(2.2%)5(3.3%)0.719MRSApts7(3.5%)1(2.2%)6(3.9%)0.587One infectionpts189(95.5%)45(100.0%)144(94.1%)Two infectionspts8(4.0%)0(0.0%)8(5.2%)0.250Three infectionspts1(0.5%)0(0.0%)1(0.7%) Bloodstreampts23(11.6%)1(2.2%)22(14.4%)0.025   Vascular catheterpts14(7.1%)1(2.2%)13(8.5%)0.149 Respiratorypts63(31.8%)3(6.7%)60(39.2%)\< 0.001  VAPpts34(17.2%)1(2.2%)33(21.6%)0.002 Urinarypts35(17.7%)5(11.1%)30(19.6%)0.189  Urinary catheterpts33(16.7%)5(11.1%)25(16.3%)0.255 Wound without operationpts2(1.0%)1(2.2%)1(0.7%)0.355 Wound with operationpts70(35.4%)35(77.8%)35(22.9%)\<0.001  Wound complication   Liquorrhoeapts14(7.1%)7(15.6%)7(4.6%)0.012   Dehiscencepts11(5.6%)9(20.0%)2(1.3%)\<0.001   Fistulapts6(3.6%)3(6.7%)3(2.0%)0.105*NICU* neurointensive care unit, *TISS* Therapeutic Intervention Scoring System, *GCS* Glasgow Coma Scale, *APACHE* Acute Physiology and Chronic Health Evaluation, *GOS* Glasgow Outcome Scale, *ESBL* Extended spectrum beta-lactamase, *MRSA* Methicillin-resistant Staphylococcus aureus, *VAP* ventilator associated pneumoniaTable 10Multivariate logistic regression analysis of nosocomial infection onset in NICUMultivariate analysisNosocomial infections predictorsOdds RatioLower CL 95%Upper CL 95%*p* valueNICU stay (per day)1.141.121.16\< 0.001Airways2.691.813.99\< 0.001Urine catheter2.771.007.700.050Transfusions1.791.072.970.025Wound complications2.301.333.970.003Antibiotic prophylaxis0.500.340.74\< 0.001*NICU* neurointensive care unit, *CL* confidence limit

Discussion {#Sec13}
==========

Maintaining nosocomial infection control management is one marker of quality in neurocritical care. Its target is to improve clinical outcomes and decrease costs in the neurocritical care unit. Preventions of nosocomial infections are an important issue in all medical or surgical critical care units, but in neurocritical care they have an additional risk as a cause of secondary brain damage, which affects the morbidity and mortality of primary brain diseases \[[@CR1]--[@CR5]\]. As the aim of neurocritical care is to avoid all insults causing secondary brain damage, preventive management of nosocomial infections is a challenge for neurointensivists. Incidence of nosocomial infections can be reduced by keeping a hygienic and epidemiological regime and rational antibiotic policy. Nosocomial infection management demands constant maintenance and stable teamwork while maintaining standard procedures. We present our preventive multimodal nosocomial infection protocol, which we implemented in our NICU. The first phase involves imposing hygienic principles and the antibiotics policy. The second phase, actually keeping to this protocol, is a much more difficult task in our experience, as a vital component for its success is the participation of the whole team, from doctors and nurses to cleaners working in the neurocritical care unit and even visitors. The use of standard procedures and meticulous checks are an important part of the regime.

Here we present the impact of our preventive nosocomial infection management on the incidence of nosocomial infections in all the patients admitted to our NICU with acute brain disease. The results show that our preventive protocol was not sufficient to completely eliminate all nosocomial infections, but it did lead to a relatively low nosocomial infection incidence of 4.4%. We did not observe differences between various seasons of the year, either among primary or secondary admissions, but we did among acute admissions, acute operations and reoperations. Infections were more frequently associated with strokes than other brain diagnoses. There were significantly more infections in airways, mechanical ventilations and catheters, but only airways and urine catheters were strong predictors in multivariate logistic regression analysis. These are still risk factors which remained despite the maintenance of the preventive strategy. Further predictors were confirmed to be the well-known factors of NICU stay, wound complications, antibiotic prophylaxis and transfusion.

The increasing colonisation of multidrug-resistant bacteria ESBL and MRSA is a big problem among critically ill patients and this situation is getting worse. At present, many patients already have these bacteria on admission and this colonization constitutes a risk of nosocomial infections \[[@CR16]--[@CR18]\]. We deal with this by completely isolating these patients using barrier care techniques in order to prevent the transmission of these multidrug-resistant ESBL and MRSA to other, uncolonised patients. This was reflected in our results, which showed that we had newly occurred ESBL in only in 31 (0.9%) patients and MRSA in 30 (0.9%) patients. In this study we did not find that multidrug-resistant bacteria were a predictor of nosocomial infections.

Antibiotics policy, predominantly the overuse of antibiotics, is another big issue in preventive multimodal nosocomial infection protocol. From our results, we see that antibiotic prophylaxis is mainly used in association with operations and only 9.7% of the total population received antibiotic therapy. Unindicated use of antibiotics contributes to the emergence and spread of multidrug-resistant bacteria, which are becoming a growing problem in healthcare facilities. Antibiotics should only be given during operations and their administration should not be prolonged in the NICU. During the prophylactic use of antibiotics it is essential not only to keep to the indication, but also to maintain the time of administration. However, this study confirmed that antibiotic prophylaxis policy is an important task, because antibiotic prophylaxis was found to be a predictor of nosocomial infection in the neurocritical care population. While using antibiotics, it is essential to maintain the correct administration and not use antibiotics during the colonisation of the patient, but only for the infection. Timing, dosage and tissue penetration are important in their administration.

Our microbiological screening was the same for all patients, who can therefore be compared easily. The unified system included nose, throat, trachea, skin, urine and rectum tests from admission, so that we would know what the patient was admitted with, and then regularly every three days. This means that this microbiological screening sometimes fell on the weekend, which at first was difficult to implement in the microbiological department. Regular microbiological screening from admission took place every three days, giving us an overview of the microbiological state of the patient and allowing us to find colonization of multidrug-resistant bacteria \[[@CR18]\] and further perform the targeted antibiotic treatment of nosocomial infections.

Although it would be better to have single-patient boxes, the lay-out of four divided rooms provides some of the benefits and enables the isolation of patients with multidrug-resistant bacteria ESBL and MRSA, as it is very important to isolate these patients so that these bacteria do not spread to the rest of the NICU and the other patients. Our results show that over a ten-year period we did not have a large incidence of the multidrug-resistant bacteria ESBL and MRSA, while there was not a single case of VRE. This is in contrast to the Minhas \[[@CR19]\] study, where he mentioned 2.5% of VRE in the neurosurgical and neurological intensive care unit.

This study confirmed that accesses are still a risk factor for nosocomial infection. Due to increasing numbers of invasive medical procedures in neurocritical care, local preventive infection control management has an important task. Although preventive multimodal strategy is widely known to reduce nosocomial infection and multidrug resistant bacteria, it is sometimes difficult to maintain. Nonetheless, the results of this study show the importance of this maintenance. We present our 10 year prospective infection control management, which was efficient, as it led to a rate of 4.4% nosocomial infections in acute neurological and neurosurgical care patients. Due to multiple testing, there is a higher probability of family-wise error. On the other hand, the results must be read in context, not every p-value below 0.05 is commented on as a finding.

This study showed prospective infection control management in 3464 neurocritically care patients. Although they all came from a single neurocentre, which is a limitation of this study, there are already many more epidemiologic studies regarding nosocomial infection control and multi-drug resistant bacteria from the medical and surgery intensive care units than from neurocritical care units, whether neurosurgical or neurological, and very few studies concerned with neurological-neurosurgical critical care units \[[@CR19], [@CR20]\]. In this area, more studies focus on specific diagnoses \[[@CR1], [@CR2], [@CR7], [@CR21], [@CR22]\] than whole neurocritical care populations.

Conclusions {#Sec14}
===========

This study showed that this preventive multimodal nosocomial infection control management was efficient, because it gave low rates of nosocomial infections (4.2%), both ESBL and MRSA in a mere 0.9% of patients each and not a single case of VRE. Strong predictors for the onset of nosocomial infections were accesses such as airways and urine catheters, NICU stay, antibiotic prophylaxis, wound complications and transfusion. This study confirmed the well-known fact that nosocomial infections are associated with worse outcome, higher cost and longer NICU stay.
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